BBC NEWS | Business | Glaxo has bird flu 'breakthrough': "UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of bird flu that may be capable of being mass produced by 2007.
The vaccine has proved effective at two doses of 3.8 micrograms during clinical trials in Belgium"
Wednesday, July 26, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment